Asset Management Resources’s Regeneron Pharmaceuticals REGN Stock Holding History

Asset Management Resources’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$393K	Sell	448 -109	-20%	-$89.8K	0.22%	33
2023 Q3	$458K	Sell	557 -15	-3%	-$11.8K	0.28%	29
2023 Q2	$411K	Sell	572 -140	-20%	-$108K	0.25%	31
2023 Q1	$585K	Sell	712 -162	-19%	-$122K	0.37%	21
2022 Q4	$631K	Sell	874 -15	-2%	-$11.1K	0.43%	23
2022 Q3	$612K	Buy	889 +29	+3%	+$18.3K	0.6%	21
2022 Q2	$508K	Sell	860 -94	-10%	-$61.1K	0.43%	22
2022 Q1	$666K	Sell	954 -14	-1%	-$8.86K	0.54%	20
2021 Q4	$611K	Buy	+968	New	+$595K	0.53%	20

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Asset Management Resources's REGN Position: Q4 2023 in Review

Asset Management Resources reduced its Regeneron Pharmaceuticals (REGN) stake by 20% in Q4 2023, selling an estimated $89.8K and leaving 448 shares worth $393K. The position accounts for 0.22% of the portfolio, ranked #33.

Asset Management Resources first reported a position in REGN in Q4 2021 and has held it in 9 quarters since. The position peaked at $666K in Q1 2022. 1,273 funds tracked by Wall St. Rank hold REGN as of Q4 2023.

Asset Management Resources held 448 shares of Regeneron Pharmaceuticals worth $393K as of Q4 2023.
Asset Management Resources sold 109 Regeneron Pharmaceuticals shares in Q4 2023, an estimated $89.8K.
Regeneron Pharmaceuticals made up 0.22% of Asset Management Resources's portfolio in Q4 2023, its #33 holding.
Asset Management Resources first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 9 quarters since.
Asset Management Resources's Regeneron Pharmaceuticals position peaked at $666K in Q1 2022.
1,273 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2023.

Based on Asset Management Resources's 13F filing for Q4 2023, filed 25 Jan 2024.